Table 7. Cumulative content of salidroside and p-tyrosol in biliary samples following i.v. and i.g. administration of salidroside (i.v. 50 mg/kg, i.g. 100 mg/kg) (n = 6).

Time (h)	i.v. administration (µg)		i.g. administration (µg)
	Salidroside	p-tyrosol	Salidroside	p-tyrosol
0–1	281.00±9.39	0.55±0.05	0.14±0.03	0.04±0.00
1–2	52.02±4.27	0.55±0.02	0.22±0.03	0.04±0.01
2–3	9.90±0.12	0.05±0.00	0.74±0.06	0.05±0.00
3–4	5.80±0.44	0.05±0.01	1.18±0.19	0.05±0.00
4–5	5.62±0.12	0.06±0.00	1.79±0.07	0.06±0.01
5–6	4.42±0.38	0.05±0.00	0.53±0.09	0.07±0.01
0–6	358.77±5.54	1.30±0.04	4.65±0.13	0.32±0.02
Excretion (% of dose)	2.86±0.04	0.02±0.00	0.02±0.00	0.00±0.00